ask="9.00"
ask_size="1100"
average_daily_volume="30179"
bid="3.00"
bid_size="1000"
book_value="3.34"
change="+0.15"
change_from_200_day_moving_average="1.25"
change_from_50_day_moving_average="2.92"
change_from_52_week_high="-1.97"
change_From_52_week_low="4.30"
change_in_percent="+1.96%"
close="7.82"
dividend_pay_date="N/A"
dividend_per_share="N/A"
dividend_yield="N/A"
earnings_per_share="-2.26"
ebitda="-50.28M"
eps_estimate_current_year="-2.60"
eps_estimate_next_quarter="-0.62"
eps_estimate_next_year="-2.84"
ex_dividend_date="N/A"
float_shares="686000"
high="7.84"
high_52_weeks="9.79"
last_trade_date="1/13/2017"
last_trade_price="7.82"
last_trade_size="200"
last_trade_time="3:47pm"
low="7.57"
low_52_weeks="3.52"
market_capitalization="166.41M"
moving_average_200_day="6.57"
moving_average_50_day="4.90"
name="Nabriva Therapeutics AG - Ameri"
notes="N/A"
one_year_target_price="16.19"
open="7.61"
pe_ratio="N/A"
peg_ratio="0.00"
percent_change_from_200_day_moving_average="+19.00%"
percent_change_from_50_day_moving_average="+59.65%"
percent_change_from_52_week_high="-20.10%"
percent_change_from_52_week_low="+122.16%"
previous_close="7.67"
price_eps_estimate_current_year="N/A"
price_eps_Estimate_next_year="N/A"
price_per_book="2.30"
price_per_sales="31.39"
revenue="5.20M"
shares_outstanding="21280000"
short_ratio="3.75"
stock_exchange="NMS"
symbol="NBRV"
volume="12398"
weeks_range_52="3.52 - 9.79"
